Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

[News in psoriasis].

Jullien D.

Ann Dermatol Venereol. 2019 Dec;146(12S):A7-A8. doi: 10.1016/j.annder.2019.09.592. Epub 2019 Oct 21. French. No abstract available.

PMID:
31648847
2.

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.

Chen DM, Odueyungbo A, Csinady E, Gearhart L, Lehane P, Cheu M, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Musette P, Joly P; French Study Group on Autoimmune Bullous Diseases.

Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18482. [Epub ahead of print]

PMID:
31487383
3.

A project of advanced solid-state neutron polarizer for PF1B instrument at Institut Laue-Langevin.

Petukhov AK, Nesvizhevsky VV, Bigault T, Courtois P, Jullien D, Soldner T.

Rev Sci Instrum. 2019 Aug;90(8):085112. doi: 10.1063/1.5114796.

PMID:
31472636
4.

Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ.

Masson Regnault M, Castañeda-Sanabria J, Diep Tran MHT, Beylot-Barry M, Bachelez H, Beneton N, Chosidow O, Dupuy A, Joly P, Jullien D, Mahé E, Richard MA, Viguier M, Tubach F, Sbidian E, Paul C; PsoBioTeq Study Group.

J Eur Acad Dermatol Venereol. 2019 Aug 16. doi: 10.1111/jdv.15878. [Epub ahead of print]

PMID:
31419355
5.

[Ustekinumab].

Jullien D, Staumont-Salle D; Groupe de recherche sur le psoriasis de la Société française de dermatologie.

Ann Dermatol Venereol. 2019 Jun - Jul;146(6-7):497-502. doi: 10.1016/j.annder.2019.04.014. Epub 2019 Jun 14. French. No abstract available.

PMID:
31208737
6.

Multiple acantholytic dyskeratotic acanthomas in a liver-transplant recipient.

Kanitakis J, Gouillon L, Jullien D, Ducroux E.

Dermatol Online J. 2019 Apr 15;25(4). pii: 13030/qt24v5t78z.

7.

[Update of the French recommendations for the management of pemphigus].

Jelti L, Prost-Squarcioni C, Ingen-Housz-Oro S, Caux F, Bernard P, Bedane C, Alexandre M, Dereure O, Quereux G, Le Bidre E, Plée J, Picard-Dahan C, Le Roux-Villet C, Duvert-Lehembre S, Richard MA, Delaporte E, Debarbieux S, Jullien D, D'Incan M, Konstantinou MP, Bouaziz JD, Tancrède-Bohin E, Doutre MS, Bourgault Villada I, Cordel N, Sassolas B, Viguier MA, Mellottée B, Jouen F, Hebert V, Joly P; Centre de référence des maladies bulleuses auto-immunes (MALIBUL); Groupe Bulles de la SFD et la Filière des maladies rares dermatologiques (FIMARAD).

Ann Dermatol Venereol. 2019 Apr;146(4):279-286. doi: 10.1016/j.annder.2019.01.018. Epub 2019 Mar 29. French. No abstract available.

PMID:
30929874
8.

High prevalence of cannabis use among patients with hidradenitis suppurativa: results from the VERADDICT survey.

Lesort C, Villani AP, Giai J, Becherel PA, Delaunay J, Fattouh K, Ducroux E, Jullien D, Guillem P.

Br J Dermatol. 2019 Oct;181(4):839-841. doi: 10.1111/bjd.17930. Epub 2019 Jun 26. No abstract available.

PMID:
30920653
9.

The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis.

Aussy A, Fréret M, Gallay L, Bessis D, Vincent T, Jullien D, Drouot L, Jouen F, Joly P, Marie I, Meyer A, Sibilia J, Bader-Meunier B, Hachulla E, Hamidou M, Huë S, Charuel JL, Fabien N, Viailly PJ, Allenbach Y, Benveniste O, Cordel N, Boyer O; OncoMyositis Study Group.

Arthritis Rheumatol. 2019 Aug;71(8):1360-1370. doi: 10.1002/art.40895. Epub 2019 Jul 8.

PMID:
30896088
10.

Successful treatment of TNFα inhibitor-resistant pityriasis rubra pilaris with ixekizumab and acitretin.

Chastagner M, Hoelt P, Kanitakis J, Jullien D, Villani AP.

Eur J Dermatol. 2019 Apr 1;29(2):218-220. doi: 10.1684/ejd.2019.3502. No abstract available.

PMID:
30827945
11.

Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.

Hébert V, Boulard C, Houivet E, Duvert Lehembre S, Borradori L, Della Torre R, Feliciani C, Fania L, Zambruno G, Camaioni DB, Didona B, Marinovic B, Schmidt E, Schumacher N, Hünefeld C, Schanz S, Kern JS, Hofmann S, Bouyeure AC, Picard-Dahan C, Prost-Squarcioni C, Caux F, Alexandre M, Ingen-Housz-Oro S, Bagot M, Tancrede-Bohin E, Bouaziz JD, Franck N, Vabres P, Labeille B, Richard MA, Delaporte E, Dupuy A, D'Incan M, Quereux G, Skowro F, Paul C, Livideanu CB, Beylot-Barry M, Doutre MS, Avenel-Audran M, Bedane C, Bernard P, Machet L, Maillard H, Jullien D, Debarbieux S, Sassolas B, Misery L, Abasq C, Dereure O, Lagoutte P, Ferranti V, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; French Study Group on Autoimmune Bullous Skin Diseases; Autoimmune Bullous Skin Disease Task Force of the European Academy of Dermatology and Venereology.

J Invest Dermatol. 2019 Jan;139(1):31-37. doi: 10.1016/j.jid.2018.04.042. Epub 2018 Oct 6. Review.

PMID:
30301637
12.

Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies.

Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, Gottlieb AB, Gisondi P, Wu JJ, Thyssen JP, Egeberg A.

J Am Acad Dermatol. 2019 Jan;80(1):251-265.e19. doi: 10.1016/j.jaad.2018.06.027. Epub 2018 Jun 19.

PMID:
29928910
13.

Basal-Cell Carcinoma With Matrical Differentiation: Report of a New Case in a Renal-Transplant Recipient and Literature Review.

Kanitakis J, Ducroux E, Hoelt P, Cahen R, Jullien D.

Am J Dermatopathol. 2018 Aug;40(8):e115-e118. doi: 10.1097/DAD.0000000000001146. Review.

PMID:
29863570
14.

[Paradoxical effects of biotherapies - A misnomer?]

Jullien D.

Ann Dermatol Venereol. 2018 Jun - Jul;145(6-7):393-394. doi: 10.1016/j.annder.2018.04.002. French. No abstract available.

PMID:
29773280
15.

sQUIZ your knowledgeǃ: A recent red lesion on the forearm.

Lesort C, Fattouh K, Martin C, Jullien D, Kanitakis J, Villani AP.

Eur J Dermatol. 2018 Apr 1;28(2):280-282. doi: 10.1684/ejd.2018.3305. No abstract available.

PMID:
29724692
16.

Clinical and Therapeutic Aspects of Linear Psoriasis: A Study of 30 Cases.

Say M, Boralévi F, Lenormand C, Bursztejn AC, Estève E, Phan A, Bourrat E, Lacour JP, Richard MA, Acher A, Jullien D, Beneton N, Descamps V, Bodemer C, Lagaude M, Chiaverini C, Mahé E; Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie, and the Groupe de Recherche de la Société Française de Dermatologie Pédiatrique.

Am J Clin Dermatol. 2018 Aug;19(4):609-615. doi: 10.1007/s40257-018-0354-9.

PMID:
29594973
17.

Psoriatic arthritis screening by the dermatologist: development and first validation of the 'PURE-4 scale'.

Audureau E, Roux F, Lons Danic D, Bagot M, Cantagrel A, Dernis E, Gouyette N, Hilliquin P, Jullien D, Lioté F, Passeron T, A Richard M, Claudepierre P.

J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1950-1953. doi: 10.1111/jdv.14861. Epub 2018 Mar 9.

PMID:
29430720
18.

sQUIZ your knowledge! Persistent facial plaques.

Theillac C, Fattouh K, Martin C, Jullien D, Villani AP, Kanitakis J.

Eur J Dermatol. 2017 Dec 1;27(6):681-683. doi: 10.1684/ejd.2017.3182. No abstract available.

PMID:
29311049
19.

Thoracic manifestations of segmental neurofibromatosis.

Chebib N, Combemale P, Jullien D, Cottin V.

BMJ Case Rep. 2017 Sep 25;2017. pii: bcr-2017-221253. doi: 10.1136/bcr-2017-221253. No abstract available.

20.

Increasing incidence of melanoma after solid organ transplantation: a retrospective epidemiological study.

Fattouh K, Ducroux E, Decullier E, Kanitakis J, Morelon E, Boissonnat P, Sebbag L, Jullien D, Euvrard S.

Transpl Int. 2017 Nov;30(11):1172-1180. doi: 10.1111/tri.13011. Epub 2017 Aug 3.

21.

Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients.

Delaunay J, Villani AP, Guillem P, Tristan A, Boibieux A, Jullien D.

Br J Dermatol. 2018 Jan;178(1):e15-e16. doi: 10.1111/bjd.15739. Epub 2017 Dec 7. No abstract available.

PMID:
28626900
22.

Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort.

Sbidian E, Giboin C, Bachelez H, Paul C, Beylot-Barry M, Dupuy A, Viguier M, Lacour JP, Schmutz JL, Bravard P, Mahé E, Beneton N, Misery L, Delaporte E, Modiano P, Barbarot S, Regnier E, Jullien D, Richard MA, Joly P, Tubach F, Chosidow O.

J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2046-2054. doi: 10.1111/jdv.14406. Epub 2017 Jul 16.

23.

Management of psoriatic arthritis among cutaneous psoriasis patients: from pathogenesis to therapy.

Hoelt P, Confavreux C, Jullien D, Villani AP.

G Ital Dermatol Venereol. 2017 Oct;152(5):458-473. doi: 10.23736/S0392-0488.17.05680-2. Epub 2017 May 23. Review.

PMID:
28534601
24.

Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study.

Egeberg A, Kristensen LE, Thyssen JP, Gislason GH, Gottlieb AB, Coates LC, Jullien D, Gisondi P, Gladman DD, Skov L, Mallbris L.

Ann Rheum Dis. 2017 Sep;76(9):1591-1597. doi: 10.1136/annrheumdis-2016-210963. Epub 2017 May 8.

PMID:
28483767
25.

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.

Joly P, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Vermeulin T, Benichou J, Musette P; French study group on autoimmune bullous skin diseases.

Lancet. 2017 May 20;389(10083):2031-2040. doi: 10.1016/S0140-6736(17)30070-3. Epub 2017 Mar 22.

PMID:
28342637
26.

Risk of Aggressive Skin Cancers After Kidney Retransplantation in Patients With Previous Posttransplant Cutaneous Squamous Cell Carcinomas: A Retrospective Study of 53 Cases.

Ducroux E, Martin C, Bouwes Bavinck JN, Decullier E, Brocard A, Westhuis-van Elsäcker ME, Lebbé C, Francès C, Morelon E, Legendre C, Joly P, Kanitakis J, Jullien D, Euvrard S, Dantal J.

Transplantation. 2017 Apr;101(4):e133-e141. doi: 10.1097/TP.0000000000001644.

PMID:
28099404
27.

The Clinical Relevance of Antifibrillarin (anti-U3-RNP) Autoantibodies in Systemic Sclerosis.

Tall F, Dechomet M, Riviere S, Cottin V, Ballot E, Tiev KP, Montin R, Morin C, Chantran Y, Grange C, Jullien D, Ninet J, Chretien P, Cabane J, Fabien N, Johanet C.

Scand J Immunol. 2017 Jan;85(1):73-79. doi: 10.1111/sji.12510.

28.

Predictors of long-term drug survival for infliximab in psoriasis.

Magis Q, Jullien D, Gaudy-Marqueste C, Baumstark K, Viguier M, Bachelez H, Guibal F, Delaporte E, Karimova E, Montaudié H, Boye T, Aubin F, Beylot-Barry M, Richard MA; “Groupe de Recherche sur le Psoriasis de la Société Française”.

J Eur Acad Dermatol Venereol. 2017 Jan;31(1):96-101. doi: 10.1111/jdv.13747. Epub 2016 Jun 21.

PMID:
27325600
29.

New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases.

Méry-Bossard L, Bagny K, Chaby G, Khemis A, Maccari F, Marotte H, Perrot JL, Reguiai Z, Sigal ML, Avenel-Audran M, Boyé T, Grasland A, Gillard J, Jullien D, Toussirot E.

J Eur Acad Dermatol Venereol. 2017 Jan;31(1):181-186. doi: 10.1111/jdv.13759. Epub 2016 Jun 13.

PMID:
27291924
30.

Active tuberculosis in psoriasis patients treated with TNF antagonists: a French nationwide retrospective study.

Guinard E, Bulai Livideanu C, Barthélémy H, Viguier M, Reguiai Z, Richard MA, Jullien D, Beneton N, Bara C, Vabres P, Grandvuillemin A, Marguery MC, Amelot F, Konstantinou MP, Bagheri H, Paul C; French Psoriasis Research Group.

J Eur Acad Dermatol Venereol. 2016 Aug;30(8):1336-41. doi: 10.1111/jdv.13633. Epub 2016 Jun 3.

PMID:
27256154
31.

Chromatibody, a novel non-invasive molecular tool to explore and manipulate chromatin in living cells.

Jullien D, Vignard J, Fedor Y, Béry N, Olichon A, Crozatier M, Erard M, Cassard H, Ducommun B, Salles B, Mirey G.

J Cell Sci. 2016 Jul 1;129(13):2673-83. doi: 10.1242/jcs.183103. Epub 2016 May 20.

32.

Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.

Faivre C, Villani AP, Aubin F, Lipsker D, Bottaro M, Cohen JD, Durupt F, Jeudy G, Sbidian E, Toussirot E, Badot V, Barbarot S, Debarbieux S, Delaporte E, Goegebeur G, Morel J, Nassif A, Duru G, Jullien D; French Society of Dermatology and Club Rheumatisms and Inflammation.

J Am Acad Dermatol. 2016 Jun;74(6):1153-9. doi: 10.1016/j.jaad.2016.01.018. Epub 2016 Mar 8.

PMID:
26965410
33.

Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis.

Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, Beylot-Barry M, Misery L, Joly P, Le Maitre M, Aractingi S, Aubin F, Cantagrel A, Ortonne JP, Jullien D.

J Am Acad Dermatol. 2015 Aug;73(2):242-8. doi: 10.1016/j.jaad.2015.05.001. Epub 2015 Jun 6. Review.

PMID:
26054432
34.

[Allgrove syndrome].

Alakeel A, Raynaud C, Rossi M, Reix P, Jullien D, Souillet AL.

Ann Dermatol Venereol. 2015 Feb;142(2):121-4. doi: 10.1016/j.annder.2014.11.012. Epub 2014 Dec 30. French.

PMID:
25554662
35.

Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra.

Saunier J, Debarbieux S, Jullien D, Garnier L, Dalle S, Thomas L.

Dermatology. 2015;230(2):97-100. doi: 10.1159/000367690. Epub 2014 Nov 27. Review.

PMID:
25471551
36.

Hidradenitis suppurativa after renal transplantation: complete remission after switching from oral cyclosporine to oral tacrolimus.

Ducroux E, Ocampo MA, Kanitakis J, Morelon E, Jullien D, Faure M, Euvrard S.

J Am Acad Dermatol. 2014 Nov;71(5):e210-1. doi: 10.1016/j.jaad.2014.06.031. Epub 2014 Oct 15. No abstract available.

37.

The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients.

Jachiet M, Flageul B, Deroux A, Le Quellec A, Maurier F, Cordoliani F, Godmer P, Abasq C, Astudillo L, Belenotti P, Bessis D, Bigot A, Doutre MS, Ebbo M, Guichard I, Hachulla E, Héron E, Jeudy G, Jourde-Chiche N, Jullien D, Lavigne C, Machet L, Macher MA, Martel C, Melboucy-Belkhir S, Morice C, Petit A, Simorre B, Zenone T, Bouillet L, Bagot M, Frémeaux-Bacchi V, Guillevin L, Mouthon L, Dupin N, Aractingi S, Terrier B; French Vasculitis Study Group.

Arthritis Rheumatol. 2015 Feb;67(2):527-34. doi: 10.1002/art.38956.

38.

Immunogenicity of biotherapy used in psoriasis: the science behind the scenes.

Jullien D, Prinz JC, Nestle FO.

J Invest Dermatol. 2015 Jan;135(1):31-38. doi: 10.1038/jid.2014.295. Epub 2014 Aug 14. Review.

39.

Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians.

Gilet H, Roborel de Climens A, Arnould B, Bachelez H, Bagot M, Beaulieu P, Joly P, Jullien D, Le Maître M, Ortonne JP, Paul C, Thibout E.

J Eur Acad Dermatol Venereol. 2015 Mar;29(3):498-506. doi: 10.1111/jdv.12601. Epub 2014 Jul 25.

40.

Treatment (biotherapy excluded) of psoriatic arthritis: an appraisal of methodological quality of international guidelines.

Sevrain M, Villani AP, Rouzaud M, Barnetche T, Paul C, Richard MA, Beylot-Barry M, Jullien D, Aractingi S, Aubin F, Joly P, Le Maitre M, Cantagrel A, Ortonne JP, Misery L.

J Eur Acad Dermatol Venereol. 2014 Aug;28 Suppl 5:33-9. doi: 10.1111/jdv.12564. Review.

PMID:
24985561
41.

Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus.

Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, Beylot-Barry M, Misery L, Joly P, Aractingi S, Aubin F, Le Maître M, Cantagrel A, Ortonne JP, Jullien D.

J Eur Acad Dermatol Venereol. 2014 Aug;28 Suppl 5:27-32. doi: 10.1111/jdv.12563. Review.

PMID:
24985560
42.

Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review.

Rouzaud M, Sevrain M, Villani AP, Barnetche T, Paul C, Richard MA, Jullien D, Misery L, Le Maître M, Aractingi S, Aubin F, Joly P, Cantagrel A, Ortonne JP, Beylot-Barry M.

J Eur Acad Dermatol Venereol. 2014 Aug;28 Suppl 5:17-26. doi: 10.1111/jdv.12562. Review.

PMID:
24985559
43.

Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion.

Sevrain M, Richard MA, Barnetche T, Rouzaud M, Villani AP, Paul C, Beylot-Barry M, Jullien D, Aractingi S, Aubin F, Joly P, Le Maitre M, Cantagrel A, Ortonne JP, Misery L.

J Eur Acad Dermatol Venereol. 2014 Aug;28 Suppl 5:13-6. doi: 10.1111/jdv.12561. Review.

PMID:
24985558
44.

Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: systematic review and expert opinion.

Richard MA, Barnetche T, Rouzaud M, Sevrain M, Villani AP, Aractingi S, Aubin F, Beylot-Barry M, Joly P, Jullien D, Le Maître M, Misery L, Ortonne JP, Cantagrel A, Paul C.

J Eur Acad Dermatol Venereol. 2014 Aug;28 Suppl 5:3-12. doi: 10.1111/jdv.12560. Review.

PMID:
24985557
45.

Clinical relevance of immunogenicity of biologics in psoriasis: implications for treatment strategies.

Carrascosa JM, van Doorn MB, Lahfa M, Nestle FO, Jullien D, Prinz JC.

J Eur Acad Dermatol Venereol. 2014 Nov;28(11):1424-30. doi: 10.1111/jdv.12549. Epub 2014 May 20. Review.

PMID:
24841895
46.

Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study.

Tauber M, Buche S, Reygagne P, Berthelot JM, Aubin F, Ghislain PD, Cohen JD, Coquerelle P, Goujon E, Jullien D, Brixi H, Jeudy G, Guennoc X, Martin A, Brénaut E, Hoppé E, Bertolotti A, Bardin T, Delaporte E, Allez M, Bachelez H, Seneschal J, Viguier M; Groupe de Recherche sur Psoriasis de Société Française de, Dermatologie; Club Rhumatismes et Inflammation (CRI); Groupe d'études thérapeutiques des affections inflammatoires du tube digestif (GETAID).

J Am Acad Dermatol. 2014 Jun;70(6):1146-9. doi: 10.1016/j.jaad.2014.03.005. No abstract available.

PMID:
24831323
47.

Skin cancers after liver transplantation: retrospective single-center study on 371 recipients.

Ducroux E, Boillot O, Ocampo MA, Decullier E, Roux A, Dumortier J, Kanitakis J, Jullien D, Euvrard S.

Transplantation. 2014 Aug 15;98(3):335-40. doi: 10.1097/TP.0000000000000051.

PMID:
24621534
48.

Cutaneous actinomycosis associated with anti-TNF-alpha therapy: report of two cases.

Breton AL, Lamblin G, Pariset C, Jullien D.

Dermatology. 2014;228(2):112-4. doi: 10.1159/000357522. Epub 2014 Feb 22.

PMID:
24577258
49.

Paradoxical psoriatic arthritis in a patient with rheumatoid arthritis treated by TNFα blocker.

Villani AP, Weiler L, Jullien D, Chapurlat R, Confavreux C.

Joint Bone Spine. 2014 Oct;81(5):455-6. doi: 10.1016/j.jbspin.2014.01.004. Epub 2014 Feb 20. No abstract available.

PMID:
24561024
50.

Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies.

Pouplard C, Brenaut E, Horreau C, Barnetche T, Misery L, Richard MA, Aractingi S, Aubin F, Cribier B, Joly P, Jullien D, Le Maître M, Ortonne JP, Paul C.

J Eur Acad Dermatol Venereol. 2013 Aug;27 Suppl 3:36-46. doi: 10.1111/jdv.12165. Review.

PMID:
23845151

Supplemental Content

Loading ...
Support Center